Based on the given dataset, here are three rules that could be used to predict if a molecule has the potential to cause adverse effects in relation to musculoskeletal and connective tissue disorders:
Rule 1: If the molecule contains a sulfonyl group (-SO2-) or a nitro group (-NO2), then it may have the potential to cause adverse effects related to musculoskeletal and connective tissue disorders. This rule applies to molecules 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 6

================================

Rule 1: The presence of a sulfonamide group in a compound may indicate its potential to cause adverse effects on musculoskeletal and connective tissues. This rule applies to compounds C19, C28, C30, C32, C34, C36, C38, and C40.
Rule 2: A compound containing a bromine atom at position 2 of the phenyl ring may have a higher likelihood of causing adverse effects on musculoskeletal and connective tissues compared to other positions. This rule applies to compound C12.
Rule 3: Compounds containing a nitro group attached to a benzene ring may be associated with adverse effects on musculoskeletal and connective tissues. This rule applies to compounds C13 and C14.

================================

Rule 1: If there is a presence of bromine atom in the molecular structure, then it may lead to adverse effects on musculoskeletal and connective tissue disorders. The given SMILES string CN(C)CCCOC1=NN(C2=CC=CC=C21)CC3=CC=CC=C3 0 contains a bromine atom which satisfies this rule.
Rule 2: If there is a presence of sulfonyl group (-SO2R) in the molecular structure, then it may lead to adverse effects on musculoskeletal and connective tissue disorders. The given SMILES string C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N 1contains a sulfonyl group which satisfies this rule.
Rule 3: If there is a presence of fluorine atoms in the molecular structure, then it may lead to adverse effects on musculoskeletal and connective tissue disorders. The given SMILES strings C(C(F)(F)F)(OC(F)F)Cl 1and C(OC(C(F)(F)F)C(F)(F)F)F 1contain two fluorine atoms each which satisfy this rule.

================================

Based on the given dataset, here are three rules that could be used to predict if a molecule has the potential to cause adverse effects in relation to musculoskeletal and connective tissue disorders:
Rule 1: If the molecule contains a sulfonamide group (-SO2NH-) or a nitro group (-NO2), then it may have the potential to cause adverse effects related to musculoskeletal and connective tissue disorders. This rule applies to molecules represented by SMILES strings CC1=C(C=C(C(=O)N1)C#N)C2=CC=NC=C2, CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3, COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2, Cc1cc(n2cccnc2)no1, CCCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O, O=C(Nc1ccccc1Oc1ccccc1)C1(C(=O)O)C2C=C(C(C1)I)C3=C(C2(Cl)Cl)C(=C(C=C3Br)Br)Cl, FSFCF3SCF3, FCCFC(F)(F)C(F)(F

================================

Based on the given dataset, here are three rules that could be used to predict if a molecule has the potential to cause adverse effects in relation to musculoskeletal and connective tissue disorders:
Rule 1: If the molecule contains a sulfonamide group (-SO2NH-), then it may have the potential to cause adverse effects related to musculoskeletal and connective tissue disorders. This rule applies to molecules represented by SMILES strings starting with "CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CCCCCC2" or "CC1=CNN(C(=O)Nc1c2ccccc2F)C2C=CC(O2)CO".
Rule 2: If the molecule contains a nitro group (-NO2) attached to an aromatic ring, then it may have the potential to cause adverse effects related to musculoskeletal and connective tissue disorders. This rule applies to molecules represented by SMILES strings starting with "CC1=cc(ccc1n2nc(C)nn2C)C(=O)Oc2ccccc2Br" or "CC1=cn(C(=O)Cn2sc(C)c(C)s2)c(C)c1C".
Rule 3: If the molecule contains two strontium ions (Sr+2), then it may have the potential to cause adverse effects related to musculoskeletal and connective tissue disorders. This rule applies to molecules represented by SMILES strings starting with "C(C1=C(Sc(=C1

================================

Rule 1: If the molecular formula contains sulfur, then it has a high probability of causing adverse effects in musculoskeletal and connective tissues. The presence of sodium ions also increases the likelihood of such effects.
Rule 2: If the molecule contains a benzene ring or other aromatic rings, it may have a higher chance of causing adverse effects on these tissues.
Rule 3: If the molecule contains a functional group like -COOH, -OH, or -NH2, it may increase its ability to bind to receptors in muscles and joints, leading to adverse effects. However, this rule should be used cautiously as some molecules containing these groups may still be safe for use.

================================

Based on the given dataset, here are three rules that could be used to predict if a molecule has the potential to cause adverse effects in relation to musculoskeletal and connective tissue disorders:
Rule 1: If the molecule contains a sulfonamide group (-SO2NH-) or a nitro group (-NO2), then it may have the potential to cause adverse effects related to musculoskeletal and connective tissue disorders. The presence of these groups indicates that the molecule may interact with proteins involved in collagen synthesis or inflammation, which could lead to adverse effects such as joint pain or muscle weakness.
Rule 2: If the molecule contains a halogen atom (such as fluorine, chlorine, bromine, or iodine) attached to a carbon atom, then it may also have the potential to cause adverse effects related to musculoskeletal and connective tissue disorders. Halogen atoms can affect the chemical and physical properties of molecules, including their reactivity and hydrophobicity, which could impact their interactions with biological systems.
Rule 3: If the molecule contains a conjugated system of double bonds between two or more adjacent carbon atoms, then it may also have the potential to cause adverse effects related to musculoskeletal and connective tissue disorders. Conjugated systems can influence the electronic structure and reactivity of molecules, which could impact their ability to bind to target proteins or modulate cellular processes.

================================

Rule 1: If a compound contains a sulfonamide group (-SO2NH-), it may have potential side effects on musculoskeletal and connective tissue disorders. The first SMILES string in the dataset has this functional group and is labeled as 1, which indicates its association with the given disorder.
Rule 2: If a compound contains a thiadiazole ring (-C2NS-), it may also have potential side effects on musculoskeletal and connective tissue disorders. The second SMILES string in the dataset has this structural feature and is labeled as 1.
Rule 3: If a compound contains both a pyridine ring (-C5H4N-) and a carbonyl group (-C=O), it may be associated with adverse reactions affecting musculoskeletal and connective tissues. The fourth SMILES string in the dataset has these features and is labeled as 1.

================================

Rule 1: If there is a presence of Gd+3 in the molecular structure, then it may lead to adverse effects on musculoskeletal and connective tissues.
Rule 2: If the molecular structure contains fluorine atoms, then it may increase the risk of causing adverse effects on musculoskeletal and connective tissues.
Rule 3: If the molecular structure has a functional group such as C=C or COOH, then it may decrease the likelihood of causing adverse effects on musculoskeletal and connective tissues.

================================

Based on the given dataset, here are three rules that could be used to predict if a molecule has the potential to cause adverse effects in relation to musculoskeletal and connective tissue disorders:
Rule 1: If the molecule contains the substructure "CC[C@H](C)[C@H]1C(=O)NC(C(=O)N[C@H](C(=O)N[C@@H](CSSCCC(=O)N[C@@H](C(=O)N1)CC2=CC=C(C=C2)OCC)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN)C(=O)NCC(=O)N)CC(=O)N)[C@@H](C)O" then it is likely to have side-effects related to musculoskeletal and connective tissue disorders. This rule was derived from the first SMILES string provided which contains this specific substructure and has been labeled as having such side-effects.
Rule 2: If the molecule contains the functional group "C(C(C(=O)[O-])[S-])C(=O)[O-].[Na+].[Na+].[Au+]" then it is unlikely to have side-effects related to musculoskeletal and connective tissue disorders. This rule was derived from the second SMILES string provided which does not contain any substructures or functional groups associated with these

================================

Rule 1: The presence of a cyano group (-CN) in a molecule may indicate potential adverse effects on musculoskeletal and connective tissue disorders. This rule applies to molecules such as CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C and CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC.
Rule 2: A molecule containing a sulfonyl group (-SO2R) may have potential adverse effects on musculoskeletal and connective tissue disorders. This rule applies to molecules such as C1C(C1N)C2=CC=CC=C2 1 and CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F 1.
Rule 3: A molecule containing a phosphate group (-OPO3R2) may also have potential adverse effects on musculoskeletal and connective tissue disorders. This rule applies to molecules such as COC(=O)OP(=O)(O)OC(c1ccc(cc1)I)c1ccccc1Br 1 and c1ccc(nc1)n1c(=O)n(c2ccc(cc2)Br)c(=O)n(c2ccc(cc2)Br)c1=O 1.

================================

Based on the given dataset, here are three rules that could be used to predict if a molecule has the potential to cause adverse effects in relation to musculoskeletal and connective tissue disorders:
Rule 1: If the molecule contains a sulfonamide group (-SO2NH2) or a similar functional group, it may have the potential to cause adverse effects related to musculoskeletal and connective tissue disorders. The presence of this group is known to cause allergic reactions and other types of toxicity.
Rule 2: If the molecule contains iodine atoms, it may also have the potential to cause adverse effects related to musculoskeletal and connective tissue disorders. Iodine is known to interfere with thyroid hormone production, which can lead to various health problems including muscle weakness and joint pain.
Rule 3: If the molecule contains a magnesium ion (Mg+2), it may not have the potential to cause adverse effects related to musculoskeletal and connective tissue disorders. Magnesium ions are important for many biological processes, so their presence does not necessarily indicate harm.

================================

Based on the given dataset, here are three rules that could be used to predict if a molecule has the potential to cause adverse effects in relation to musculoskeletal and connective tissue disorders:
Rule 1: If the molecule contains a sulfonamide group (-SO2NH-) or a nitro group (-NO2), then it may have the potential to cause adverse effects related to musculoskeletal and connective tissue disorders. The presence of these groups indicates that the molecule may interact with proteins involved in collagen synthesis or inflammation, which could lead to adverse effects such as joint pain or muscle weakness.
Rule 2: If the molecule contains a halogen atom (such as fluorine, chlorine, bromine, or iodine) attached to a carbon atom, then it may also have the potential to cause adverse effects related to musculoskeletal and connective tissue disorders. Halogen atoms can affect the chemical and physical properties of molecules, including their reactivity and hydrophobicity, which could impact their interactions with biological systems.
Rule 3: If the molecule contains a conjugated system of double bonds between two or more adjacent carbon atoms, then it may also have the potential to cause adverse effects related to musculoskeletal and connective tissue disorders. Conjugated systems can influence the electronic structure and reactivity of molecules, which could impact their ability to bind to target proteins or modulate cellular processes.

================================

Based on the given dataset, here are three rules that could be used to predict if a molecule has the potential to cause adverse effects in relation to musculoskeletal and connective tissue disorders:
Rule 1: If the molecule contains a sulfonamide group (-SO2NH2) or a sulfonyl group (-SO2R), then it may have the potential to cause adverse effects related to musculoskeletal and connective tissue disorders. This rule applies to molecules 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63

================================

Rule 1: If there is a presence of chlorine atom in the structure, then it may lead to adverse effects on Musculoskeletal and Connective Tissue Disorders. The first SMILE string has Chlorine present which matches this rule.
Rule 2: If there is a presence of Nitrogen atoms in the structure along with other functional groups like carbonyl group or double bonds, then it may also lead to Adverse Effects on Musculoskeletal and Connective Tissue Disorders. The second SMILE string has both nitrogen and carbonyl group present which matches this rule.
Rule 3: If there is a presence of aromatic rings in the structure, then it may have some potential for causing adverse effects but it cannot be solely relied upon as it depends on various factors such as size, shape, charge distribution etc. The third SMILE string has an aromatic ring present which does not match any of these two rules.

================================

Rule 1: The presence of a sulfhydryl group in a compound may indicate its potential for causing adverse effects on musculoskeletal and connective tissues. This rule applies to the first SMILE string provided where the sulfur atom is present as part of a thiol group (-SH).
Rule 2: A compound containing a conjugated system of double bonds or aromatic rings may have a higher likelihood of causing adverse effects on these tissues. This rule applies to the second SMILE string provided which contains two phenyl groups connected by a triple bond.
Rule 3: A compound containing a carbonyl group (C=O) may be associated with increased risk of adverse effects on musculoskeletal and connective tissues. This rule applies to the third SMILE string provided where there is a ketone functional group (-C(=O)-) present.

================================

Rule 1: The presence of a carbonyl group (C=O) in a compound may indicate potential toxicity or adverse effects on musculoskeletal and connective tissues. This rule applies to compounds represented by SMILES strings labeled as 1 for which the structure contains at least one carbon-oxygen double bond. For example, the first compound listed has a carbonyl group attached to a long chain of carbons, which could potentially disrupt normal cell function if the compound were to interact with proteins involved in muscle or bone development.
Rule 2: The presence of a heterocyclic ring structure containing nitrogen atoms may also increase the likelihood of adverse effects on musculoskeletal and connective tissues. This rule applies to compounds represented by SMILES strings labeled as 1 for which the structure contains at least one five-membered ring with one or more nitrogen atoms. For example, the fourth compound listed has a pyrimidine ring structure, which is a type of heterocyclic ring commonly found in DNA and RNA molecules. Nitrogen atoms in this ring structure have a partial positive charge, which could potentially interact with negatively charged amino acid residues in proteins involved in muscle or bone development.
Rule 3: Compounds with a sulfonamide functional group (R-SO2NH2) may be associated with adverse effects on musculoskeletal and connective tissues. This rule applies to compounds represented by SMILES strings labeled as 1 for which the structure contains a sulfur atom bonded to two oxygen atoms and one nitrogen atom. Sulfonamides are a class of antibiotics that inhibit the growth of bacteria by blocking the production of folic acid, which is essential for cell division. However, some studies suggest that sulfonamides may also affect the formation of cartilage and bone in developing embryos, leading to

================================

Based on the given dataset, here are three rules that could be used to predict if a molecule has the potential to cause adverse effects in relation to musculoskeletal and connective tissue disorders:
Rule 1: If the molecule contains a sulfonyl group (-SO2-) or a nitro group (-NO2), then it may have the potential to cause adverse effects related to musculoskeletal and connective tissue disorders. This rule applies to molecules 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 6

================================

Based on the given dataset, here are three rules that could be used to predict if a molecule has the potential to cause adverse effects in relation to musculoskeletal and connective tissue disorders:
Rule 1: If the molecule contains a sulfonamide group (-SO2NH-), then it may have the potential to cause adverse effects related to musculoskeletal and connective tissue disorders. This rule applies to molecules represented by SMILES strings starting with "CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CCCCCC2" or "CC1=CNN(C(=O)Nc1c2ccccc2F)C2C=CC(O2)CO".
Rule 2: If the molecule contains a nitro group (-NO2) attached to an aromatic ring, then it may have the potential to cause adverse effects related to musculoskeletal and connective tissue disorders. This rule applies to molecules represented by SMILES strings starting with "CC1=cc(ccc1n2nc(C)nn2C)C(=O)Oc2ccccc2Br" or "CC1=cn(C(=O)Cn2sc(C)c(C)s2)c(C)c1C".
Rule 3: If the molecule contains two strontium ions (Sr+2), then it may have the potential to cause adverse effects related to musculoskeletal and connective tissue disorders. This rule applies to molecules represented by SMILES strings starting with "C(C1=C(Sc(=C1

================================



================================

Rule 1: If a compound contains a sulfonamide group (-SO2NH-), it may have potential side effects on musculoskeletal and connective tissue disorders. The first SMILES string in the dataset has this functional group and is labeled as 1, which indicates its association with the given disorder.
Rule 2: If a compound contains a thiadiazole ring (-C2NS-), it may also have potential side effects on musculoskeletal and connective tissue disorders. The second SMILES string in the dataset has this structural feature and is labeled as 1.
Rule 3: If a compound contains both a pyridine ring (-C5H4N-) and a carbonyl group (-C=O), it may be associated with adverse reactions affecting musculoskeletal and connective tissues. The fourth SMILES string in the dataset has these features and is labeled as 1.

================================

Rule 1: The presence of certain functional groups in a molecule may increase its likelihood of causing adverse effects on musculoskeletal and connective tissue disorders. For example, the presence of a sulfonamide group in the first SMILES string suggests potential toxicity towards these tissues.
Rule 2: The length and complexity of a molecule may also play a role in determining its ability to cause adverse effects. For instance, the second SMILES string contains a long chain of carbon atoms that may affect its bioavailability or metabolism.
Rule 3: The specific arrangement of atoms within a molecule may be important for predicting its biological activity. For example, the third SMILES string contains several rings and double bonds that may contribute to its stability and reactivity.

================================

Rule 1: The presence of a carbonyl group (C=O) in a compound may indicate potential toxicity or adverse effects on musculoskeletal and connective tissues. This rule applies to compounds represented by SMILES strings labeled as 1 for which the structure contains at least one carbon-oxygen double bond. For example, the first compound listed has a carbonyl group attached to a long chain of carbons, which could potentially disrupt normal cell function if the compound were to interact with proteins involved in muscle or bone development.
Rule 2: The presence of a heterocyclic ring structure containing nitrogen atoms may also increase the likelihood of adverse effects on musculoskeletal and connective tissues. This rule applies to compounds represented by SMILES strings labeled as 1 for which the structure contains at least one five-membered ring with one or more nitrogen atoms. For example, the fourth compound listed has a pyrimidine ring structure, which is a type of heterocyclic ring commonly found in DNA and RNA molecules. Nitrogen atoms in this ring structure have a partial positive charge, which could potentially interact with negatively charged amino acid residues in proteins involved in muscle or bone development.
Rule 3: Compounds with a sulfonamide functional group (R-SO2NH2) may be associated with adverse effects on musculoskeletal and connective tissues. This rule applies to compounds represented by SMILES strings labeled as 1 for which the structure contains a sulfur atom bonded to two oxygen atoms and one nitrogen atom. Sulfonamides are a class of antibiotics that inhibit the growth of bacteria by blocking the production of folic acid, which is essential for cell division. However, some studies suggest that sulfonamides may also affect the formation of cartilage and bone in developing embryos, leading to

================================

Based on the given dataset, here are three rules that could be used to predict if a molecule has the potential to cause adverse effects in relation to musculoskeletal and connective tissue disorders:
Rule 1: If the molecule contains a sulfonamide group (-SO2NH-), then it may have the potential to cause adverse effects related to musculoskeletal and connective tissue disorders. This rule applies to molecules 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73

================================

Rule 1: If there exists a sulfonamide group in the structure of a molecule, then it may have potential side effects on musculoskeletal and connective tissue disorders. The presence of this functional group can be identified by checking for the SMILES string "SO2NH" or "R-SO2NR'" where R and R' can be any organic substituent.
Rule 2: If a molecule contains a nitro group (-NO2), then it may also have potential side effects on musculoskeletal and connective tissue disorders. This functional group can be identified by checking for the SMILES string "NO2".
Rule 3: If a molecule has a halogen atom such as chlorine (Cl) attached to its aromatic ring system, then it may have potential side effects on musculoskeletal and connective tissue disorders. This structural feature can be identified by checking for the SMILES string "Ar-X" where Ar represents an aromatic ring and X represents a halogen atom.

================================

Rule 1: The presence of a sulfonamide group in a compound may increase its potential for causing adverse effects on musculoskeletal and connective tissue disorders. This rule can be inferred from the fact that two out of three molecules labeled as 1 contain a sulfonamide group while none of the molecules labeled as 0 do.
Rule 2: A compound containing a benzimidazole ring may have a higher likelihood of causing adverse effects on musculoskeletal and connective tissue disorders compared to compounds without this ring. This rule can be inferred from the fact that one molecule labeled as 1 contains a benzimidazole ring while no molecules labeled as 0 do.
Rule 3: A compound containing a chlorine atom at position 2 of the phenyl ring may have a lower risk of causing adverse effects on musculoskeletal and connective tissue disorders than those without such substitution. This rule can be inferred from the fact that all four molecules labeled as 0 contain a chlorine atom at position 2 of the phenyl ring while only one molecule labeled as 1 does not.

================================

Rule 1: The presence of a sulfonamide group in a compound may indicate its potential to cause adverse effects on musculoskeletal and connective tissues. This rule applies to compounds C19, C28, C30, C32, C34, C36, C38, and C40.
Rule 2: A compound containing a bromine atom at position 2 of the phenyl ring may have a higher likelihood of causing adverse effects on musculoskeletal and connective tissues compared to other positions. This rule applies to compound C12.
Rule 3: Compounds containing a nitro group attached to a benzene ring may be associated with adverse effects on musculoskeletal and connective tissues. This rule applies to compounds C13 and C14.

================================

Based on the given dataset, here are three rules that could be used to predict if a molecule has the potential to cause adverse effects in relation to musculoskeletal and connective tissue disorders:
Rule 1: If the molecule contains a bromine atom, it is likely to have side-effects related to musculoskeletal and connective tissue disorders. The presence of bromine indicates that the molecule may interact with biological systems in ways that could lead to these types of adverse effects.
Rule 2: If the molecule contains a carbonyl group (represented by the symbol C=O), it is also likely to have side-effects related to musculoskeletal and connective tissue disorders. Carbonyl groups can participate in chemical reactions that can affect the function of proteins and other molecules within cells, which could lead to negative consequences for tissues and organs throughout the body.
Rule 3: If the molecule contains a nitro group (represented by the symbol NO2), it is less likely to have side-effects related to musculoskeletal and connective tissue disorders. Nitro groups are often associated with toxic or carcinogenic properties, so their presence in a molecule may indicate that it has more severe negative impacts on biological systems than those related to musculoskeletal and connective tissue disorders.

================================

Rule 1: The presence of a sulfonamide group in a compound may indicate its potential to cause adverse effects on musculoskeletal and connective tissues. This rule applies to compounds C19, C28, C30, C32, C34, C36, C38, and C40.
Rule 2: A compound containing a bromine atom at position 2 of the phenyl ring may have a higher likelihood of causing adverse effects on musculoskeletal and connective tissues compared to other positions. This rule applies to compound C12.
Rule 3: Compounds containing a nitro group attached to a benzene ring may be associated with adverse effects on musculoskeletal and connective tissues. This rule applies to compounds C13 and C14.

================================

Rule 1: The presence of a sulfonamide group in a compound may indicate its potential to cause adverse effects on musculoskeletal and connective tissues. This rule applies to compounds C19, C28, C30, C32, C34, C36, C38, and C40.
Rule 2: A compound containing a bromine atom at position 2 of the phenyl ring may have a higher likelihood of causing adverse effects on musculoskeletal and connective tissues compared to other positions. This rule applies to compound C12.
Rule 3: Compounds containing a nitro group attached to a benzene ring may be associated with adverse effects on musculoskeletal and connective tissues. This rule applies to compounds C13 and C14.

================================

